Octapharma AG Hosts Symposium at WFH World Congress on Meeting the Challenges of Von Willebrand Disease (VWD) Diagnosis and Treatment  
7/25/2012 9:35:44 AM

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma AG, a leading producer of human proteins for life saving therapies, sponsored a symposium entitled “Meeting the challenges of VWD diagnosis and treatment- Which problems have we solved?” This symposium was held on July 11, 2012 during the 30th Congress of World Federation of Haemophilia in Paris, France.